Characteristics Associated With <scp>EuroLupus</scp> Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis

For children and young adults with LN requiring CYC, use of the EuroLupus regimen increased over time and is associated with demographic and clinical factors such as race or Hispanic ethnicity, renal impairment, and absence of neuropsychiatric involvement. The differences in regimen use with severe renal impairment and neuropsychiatric lupus highlight areas for future study in CYC dosing.

Authors

Institutions

Publication Details

Journal
ACR Open Rheumatology
Published
2025-11-26
DOI
https://doi.org/10.1002/acr2.70132
Primary Topic
Systemic Lupus Erythematosus Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis

Nicole Ling, Meredith Riebschleger, Jennifer C. Cooper, Stacy P. Ardoin et al.
ACR Open Rheumatology
Systemic Lupus Erythematosus Research
article

Characteristics Associated With EuroLupus Versus Modified National Institutes of Health Cyclophosphamide Regimen Use in Children and Young Adults With Lupus Nephritis

Nicole Ling, Meredith Riebschleger, Jennifer C. Cooper, Stacy P. Ardoin, Aliese Sarkissian, Marinka Twilt, Julia Shalen, Scott E. Wenderfer, Kelly Rouster‐Stevens, Kristen Miller, Emily Hause, Rebecca E. Sadun, Wenru Zhou, William Daniel Soulsby, Christine Bearer, Joyce Hui‐Yuen, Laura B. Lewandowski, Eveline Y. Wu, Maria Pereira, Christine Wang
article en

Abstract

For children and young adults with LN requiring CYC, use of the EuroLupus regimen increased over time and is associated with demographic and clinical factors such as race or Hispanic ethnicity, renal impairment, and absence of neuropsychiatric involvement. The differences in regimen use with severe renal impairment and neuropsychiatric lupus highlight areas for future study in CYC dosing.

ACR Open RheumatologyVol. 7(12)
University of North Carolina at Chapel Hill (US), Fairview Health Services (US), University of British Columbia (CA), Johns Hopkins University (US), Duke University (US), University of California, San Francisco (US), Johns Hopkins Medicine (US), Alberta Children's Hospital (CA), National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), Akron Children's Hospital (US), Ohio State University Hospital (US), Cohen Children's Medical Center (US), Children's Healthcare of Atlanta (US), Texas Children's Hospital (US), C. S. Mott Children's Hospital (US), University of Minnesota Children's Hospital (US), University of Colorado Anschutz Medical Campus (US), The Ohio State University (US)
Openalex Percentile: Top 48%
Systemic Lupus Erythematosus Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.